Skip to main content

What the FDA labels say about taking them together

Omeprazole and sofosbuvir/velpatasvir

Sofosbuvir/velpatasvir's FDA label of June 5, 2024 names omeprazole in its drug interactions section; the omeprazole labels PlainMeds reads (2) do not name sofosbuvir/velpatasvir. The sofosbuvir/velpatasvir label: “Proton-pump inhibitors (e.g., omeprazole) Coadministration of omeprazole or other proton-pump inhibitors is not recommended.”

Check it at the source: the omeprazole FDA label on DailyMed (effective April 22, 2024, Apotex Corp); the sofosbuvir/velpatasvir FDA label on DailyMed (effective June 5, 2024, Gilead Sciences, Inc.).

What does the omeprazole label say about sofosbuvir/velpatasvir?

Omeprazole's label (effective April 22, 2024) and its 1 other brand-application label do not name sofosbuvir/velpatasvir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Omeprazole), Apotex Corp, effective April 22, 2024 (SPL set b83329ac-a65e-b3af-a3fb-c5a6c740e5e7), via openFDA; the full label on DailyMed

What does the sofosbuvir/velpatasvir label say about omeprazole?

Sofosbuvir/velpatasvir label, drug interactions

Proton-pump inhibitors (e.g., omeprazole) Coadministration of omeprazole or other proton-pump inhibitors is not recommended.

Source: FDA drug label (Epclusa), Gilead Sciences, Inc., effective June 5, 2024 (SPL set 7f30631a-ee3b-4cfe-866b-964df3f0a44f), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

118Omeprazole generic labelers
0Sofosbuvir/velpatasvir generic labelers
OmeprazoleSofosbuvir/velpatasvir
Labeled forAcid reflux and ulcersHepatitis C
Boxed warningNoYes
Pharmacy cost (NADAC)$0.0295 per capsule 20 mg capsule$278.03 per unit 400-100
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?